SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivimed Labs informs about revised statement of impact on audit qualifications & declaration

05 Jul 2023 Evaluate

Vivimed Labs has informed that it enclosed the statement on Impact of Audit Qualifications & Declaration for the Financial Year Ended March 31st, 2023, (Regulation 33 / 52 of the SEBI (LODR) (Amendment), Regulations, 2016).

The above information is a part of company’s filings submitted to BSE.

Vivimed Labs Share Price

6.28 0.21 (3.46%)
12-Jun-2026 15:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1803.75
Dr. Reddys Lab 1273.80
Cipla 1386.45
Zydus Lifesciences 1103.00
Lupin 2292.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: